FDA Recalls Finder

FDA Approves A High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older
22 December 2009, 11:00 pm

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

Source: Food and Drug Administration--Press Releases